What You Should Know:
– Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.
– Built in collaboration with Mayo Clinic, the AI allows…
Continue Reading
Pioneering AIxSCAN, Inc. introduces the ARC60, an AI-driven tomosynthesis X-ray imaging system poised to revolutionize lung disease diagnosis. Clinical trials demonstrate promising results, igniting anticipation for FDA approval in 2024. Supported by cutting-edge technology…
Continue Reading
What You Should Know:
– Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update,…
Continue Reading
By Anuja Vaidya
January 19, 2024 – A team providing palliative care via audio-only telehealth helped improve the quality of life for adults with chronic conditions like chronic obstructive pulmonary disease (COPD), heart failure, and interstitial…
Continue Reading
To address rural healthcare access disparities, the Advanced Research Projects Agency for Health office at the National Institutes of Health seeks to create a scalable vehicle platform that can provide advanced medical services outside…
Continue Reading
The merger between 4D Medical and Imbio heralds a revolutionary shift in respiratory health technology. By combining their pioneering lung imaging and analysis technologies, the partnership aims to transform standard chest CT scans into…
Continue Reading
A study has found that admissions and hospital bed days were both reduced by 50% for high-risk COPD patients using a digital support service, reducing the burden on over-stretched healthcare services. Using a digital support…
Continue Reading
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for chronic obstructive pulmonary disease patients in…
Continue Reading
What You Should Know: FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, and Eko Health, Inc. (“Eko”), a leading innovator in digital health technology for heart and lung disease detection, today announced the…
Continue Reading
Data analytics company Qureight has entered into a multi-year strategic research collaboration with AstraZeneca that will use AI models to accelerate research into lung diseases.Through the agreement, AstraZeneca will use Qureight’s proprietary analytics platform…
Continue Reading
